Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY
- Authors
- Lee, WS[Lee, W-S.]; Kim, HJ[Kim, H-J.]; Kong, JH[Kong, J. H.]; Kim, H[Kim, H.]; Do, YR[Do, Y. R.]; Kwak, JY[Kwak, J-Y.]; Oh, S[Oh, S.]; Kim, SH[Kim, S. H.]; Kim, JA[Kim, J-A.]; Zang, DY[Zang, D. Y.]; Mun, YC[Mun, Y-C.]; Won, YW[Won, Y-W.]; Lee, SE[Lee, S-E.]; Choi, SY[Choi, S-Y.]; Kim, SH[Kim, S-H.]; Choi, MY[Choi, M-Y.]; Kim, DW[Kim, D-W.]
- Issue Date
- 26-Jun-2017
- Publisher
- FERRATA STORTI FOUNDATION
- Citation
- HAEMATOLOGICA, v.102, pp.434 - 434
- Indexed
- SCIE
SCOPUS
- Journal Title
- HAEMATOLOGICA
- Volume
- 102
- Start Page
- 434
- End Page
- 434
- ISSN
- 0390-6078
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.